{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:11:39Z","timestamp":1791148299141,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1124\/jpet.107.133330","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T02:57:01Z","timestamp":1196823421000},"page":"1146-1154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency"],"prefix":"10.1016","volume":"324","author":[{"given":"Bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen G.","family":"Duysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Lockridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.133330_bib1","doi-asserted-by":"crossref","unstructured":"Adler M, Manley HA, Purcell AL, Deshpande SS, Hamilton TA, Kan RK, Oyler G, Lockridge O, Duysen EG, and Sheridan RE (2004) Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve 30: 317\u2013327.","DOI":"10.1002\/mus.20099"},{"key":"10.1124\/jpet.107.133330_bib2","doi-asserted-by":"crossref","unstructured":"Bang U, Viby-Mogensen J, Wiren JE, and Skovgaard LT (1990) The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients. Acta Anaesthesiol Scand 34: 596 \u2013599.","DOI":"10.1111\/j.1399-6576.1990.tb03152.x"},{"key":"10.1124\/jpet.107.133330_bib3","unstructured":"Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, and La Du BN (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50: 1086 \u20131103."},{"key":"10.1124\/jpet.107.133330_bib4","doi-asserted-by":"crossref","unstructured":"Becker-Follmann J, Gaa A, Bausch E, Natt E, Scherer G, and von Deimling O (1997) High-resolution mapping of a linkage group on mouse chromosome 8 conserved on human chromosome 16Q. Mamm Genome 8: 172\u2013177.","DOI":"10.1007\/s003359900384"},{"key":"10.1124\/jpet.107.133330_bib5","doi-asserted-by":"crossref","unstructured":"Bernard V, Brana C, Liste I, Lockridge O, and Bloch B (2003) Dramatic depletion of cell surface m2 muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice. Mol Cell Neurosci 23: 121\u2013133.","DOI":"10.1016\/S1044-7431(03)00034-4"},{"key":"10.1124\/jpet.107.133330_bib6","doi-asserted-by":"crossref","unstructured":"Bhat VB, Choi MH, Wishnok JS, and Tannenbaum SR (2005) Comparative plasma proteome analysis of lymphoma-bearing SJL mice. J Proteome Res 4: 1814 \u20131825.","DOI":"10.1021\/pr0501463"},{"key":"10.1124\/jpet.107.133330_bib7","doi-asserted-by":"crossref","unstructured":"Boudinot E, Taysse L, Daulon S, Chatonnet A, Champagnat J, and Foutz AS (2005) Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Pharmacol Biochem Behav 80: 53\u201361.","DOI":"10.1016\/j.pbb.2004.10.014"},{"key":"10.1124\/jpet.107.133330_bib8","doi-asserted-by":"crossref","unstructured":"Chatonnet F, Boudinot E, Chatonnet A, Taysse L, Daulon S, Champagnat J, and Foutz AS (2003) Respiratory survival mechanisms in acetylcholinesterase knock-out mouse. Eur J Neurosci 18: 1419 \u20131427.","DOI":"10.1046\/j.1460-9568.2003.02867.x"},{"key":"10.1124\/jpet.107.133330_bib9","doi-asserted-by":"crossref","unstructured":"Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, and Martin BR (1998) Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 284: 1058 \u20131065.","DOI":"10.1016\/S0022-3565(24)37303-3"},{"key":"10.1124\/jpet.107.133330_bib10","doi-asserted-by":"crossref","unstructured":"Darvesh S, MacDonald SE, Losier AM, Martin E, Hopkins DA, and Armour JA (1998) Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity. J Auton Nerv Syst 71: 75\u201384.","DOI":"10.1016\/S0165-1838(98)00064-2"},{"key":"10.1124\/jpet.107.133330_bib11","doi-asserted-by":"crossref","unstructured":"Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, and Wess J (2002) Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62: 1084 \u20131093.","DOI":"10.1124\/mol.62.5.1084"},{"key":"10.1124\/jpet.107.133330_bib12","doi-asserted-by":"crossref","unstructured":"Duysen EG, Li B, Darvesh S, and Lockridge O (2007) Sensitivity of butyrylcholinesterase knockout mice to (\u2013)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer\u2019s disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology 233: 60\u201369.","DOI":"10.1016\/j.tox.2006.11.069"},{"key":"10.1124\/jpet.107.133330_bib13","doi-asserted-by":"crossref","unstructured":"Duysen EG, Stribley JA, Fry DL, Hinrichs SH, and Lockridge O (2002) Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res Dev Brain Res 137: 43\u201354.","DOI":"10.1016\/S0165-3806(02)00367-X"},{"key":"10.1124\/jpet.107.133330_bib14","doi-asserted-by":"crossref","unstructured":"Ellman GL, Courtney KD, Andres V Jr, and Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88 \u201395.","DOI":"10.1016\/0006-2952(61)90145-9"},{"key":"10.1124\/jpet.107.133330_bib15","doi-asserted-by":"crossref","unstructured":"Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, and Nathanson NM (1997) Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci U S A 94: 13311\u201313316.","DOI":"10.1073\/pnas.94.24.13311"},{"key":"10.1124\/jpet.107.133330_bib16","doi-asserted-by":"crossref","unstructured":"Holmes C, Ballard C, Lehmann D, David Smith A, Beaumont H, Day IN, Nadeem Khan M, Lovestone S, McCulley M, Morris CM, et al. (2005) Rate of progression of cognitive decline in Alzheimer\u2019s disease: effect of butyrylcholinesterase K gene variation. J Neurol Neurosurg Psychiatry 76: 640\u2013643.","DOI":"10.1136\/jnnp.2004.039321"},{"key":"10.1124\/jpet.107.133330_bib17","doi-asserted-by":"crossref","unstructured":"Hosea NA, Berman HA, and Taylor P (1995) Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases. Biochemistry 34: 11528 \u201311536.","DOI":"10.1021\/bi00036a028"},{"key":"10.1124\/jpet.107.133330_bib18","doi-asserted-by":"crossref","unstructured":"Karnovsky MJ and Roots L (1964) A \u201cdirect-coloring\u201d thiocholine method for cholinesterases. J Histochem Cytochem 12: 219 \u2013221.","DOI":"10.1177\/12.3.219"},{"key":"10.1124\/jpet.107.133330_bib19","doi-asserted-by":"crossref","unstructured":"Li B, Duysen EG, Saunders TL, and Lockridge O (2006) Production of the butyrylcholinesterase knockout mouse. J Mol Neurosci 30: 193\u2013195.","DOI":"10.1385\/JMN:30:1:193"},{"key":"10.1124\/jpet.107.133330_bib20","doi-asserted-by":"crossref","unstructured":"Li B, Duysen EG, Volpicelli-Daley LA, Levey AI, and Lockridge O (2003) Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice. Pharmacol Biochem Behav 74: 977\u2013986.","DOI":"10.1016\/S0091-3057(03)00022-4"},{"key":"10.1124\/jpet.107.133330_bib21","doi-asserted-by":"crossref","unstructured":"Lockridge O (1990) Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47: 35\u201360.","DOI":"10.1016\/0163-7258(90)90044-3"},{"key":"10.1124\/jpet.107.133330_bib22","doi-asserted-by":"crossref","unstructured":"Manoharan I, Boopathy R, Darvesh S, and Lockridge O (2007) A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clin Chim Acta 378: 128 \u2013135.","DOI":"10.1016\/j.cca.2006.11.005"},{"key":"10.1124\/jpet.107.133330_bib23","doi-asserted-by":"crossref","unstructured":"Manoharan I, Wieseler S, Layer P, Lockridge O, and Boopathy R (2006) Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India. Pharmacogenet Genomics 16: 461\u2013468.","DOI":"10.1097\/01.fpc.0000197464.37211.77"},{"key":"10.1124\/jpet.107.133330_bib24","doi-asserted-by":"crossref","unstructured":"Maslanski JA, Powelt R, Deirmengiant C, and Patelt J (1994) Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice. Neurosci Lett 168: 225\u2013228.","DOI":"10.1016\/0304-3940(94)90456-1"},{"key":"10.1124\/jpet.107.133330_bib25","doi-asserted-by":"crossref","unstructured":"Maxwell DM, Brecht KM, and O\u2019Neill BL (1987) The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett 39: 35\u201342.","DOI":"10.1016\/0378-4274(87)90254-2"},{"key":"10.1124\/jpet.107.133330_bib26","doi-asserted-by":"crossref","unstructured":"McDaniel KL and Moser VC (1993) Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin. Neurotoxicol Teratol 15: 71\u201383.","DOI":"10.1016\/0892-0362(93)90065-V"},{"key":"10.1124\/jpet.107.133330_bib27","doi-asserted-by":"crossref","unstructured":"Mentlein R and Heymann E (1984) Hydrolysis of ester- and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver. Biochem Pharmacol 33: 1243\u20131248.","DOI":"10.1016\/0006-2952(84)90176-X"},{"key":"10.1124\/jpet.107.133330_bib28","doi-asserted-by":"crossref","unstructured":"Mentlein R, Ronai A, Robbi M, Heymann E, and von Deimling O (1987) Genetic identification of rat liver carboxylesterases isolated in different laboratories. Biochim Biophys Acta 913: 27\u201338.","DOI":"10.1016\/0167-4838(87)90228-7"},{"key":"10.1124\/jpet.107.133330_bib29","doi-asserted-by":"crossref","unstructured":"Mentlein R, Suttorp M, and Heymann E (1984) Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes. Arch Biochem Biophys 228: 230\u2013246.","DOI":"10.1016\/0003-9861(84)90064-X"},{"key":"10.1124\/jpet.107.133330_bib30","doi-asserted-by":"crossref","unstructured":"O\u2019Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O\u2019Brien JT, Swan AG, Fairbairn AF, Wesnes K, et al. (2003) Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 13: 231\u2013239.","DOI":"10.1097\/00008571-200304000-00008"},{"key":"10.1124\/jpet.107.133330_bib31","doi-asserted-by":"crossref","unstructured":"Ostergaard D, Rasmussen SN, Viby-Mogensen J, Pedersen NA, and Boysen R (2000) The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. Anesthesiology 92: 1581\u20131587.","DOI":"10.1097\/00000542-200006000-00014"},{"key":"10.1124\/jpet.107.133330_bib32","doi-asserted-by":"crossref","unstructured":"Rachinsky TL, Camp S, Li Y, Ekstrom TJ, Newton M, and Taylor P (1990) Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species. Neuron 5: 317\u2013327.","DOI":"10.1016\/0896-6273(90)90168-F"},{"key":"10.1124\/jpet.107.133330_bib33","doi-asserted-by":"crossref","unstructured":"Radi\u0107 Z and Taylor P (2001) Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex. J Biol Chem 276: 4622\u20134633.","DOI":"10.1074\/jbc.M006855200"},{"key":"10.1124\/jpet.107.133330_bib34","doi-asserted-by":"crossref","unstructured":"Ronai A, Berning W, Gaa A, and von Deimling O (1993) Esterase-30 (ES-30) of the house mouse: biochemical characterization and genetics of a new carboxylesterase isozyme linked to cluster-2 loci on chromosome 8. Biochem Genet 31: 279 \u2013294.","DOI":"10.1007\/BF00553171"},{"key":"10.1124\/jpet.107.133330_bib35","doi-asserted-by":"crossref","unstructured":"Schmitteckert EM, Prokop CM, and Hedrich HJ (1999) DNA detection in hair of transgenic mice: a simple technique minimizing the distress on the animals. Lab Anim 33: 385\u2013389.","DOI":"10.1258\/002367799780487922"},{"key":"10.1124\/jpet.107.133330_bib36","doi-asserted-by":"crossref","unstructured":"Tunek A and Svensson LA (1988) Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood. Drug Metab Dispos 16: 759 \u2013764.","DOI":"10.1016\/S0090-9556(25)07050-3"},{"key":"10.1124\/jpet.107.133330_bib37","doi-asserted-by":"crossref","unstructured":"Volpicelli-Daley LA, Hrabovska A, Duysen EG, Ferguson SM, Blakely RD, Lockridge O, and Levey AI (2003) Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol Pharmacol 64: 1309 \u20131316.","DOI":"10.1124\/mol.64.6.1309"},{"key":"10.1124\/jpet.107.133330_bib38","doi-asserted-by":"crossref","unstructured":"Wadkins RM, Hyatt JL, Wei X, Yoon KJ, Wierdl M, Edwards CC, Morton CL, Obenauer JC, Damodaran K, Beroza P, et al. (2005) Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. J Med Chem 48: 2906 \u20132915.","DOI":"10.1021\/jm049011j"},{"key":"10.1124\/jpet.107.133330_bib39","doi-asserted-by":"crossref","unstructured":"Wang H, Shi H, Lu Y, Yang B, and Wang Z (1999) Pilocarpine modulates the cellular electrical properties of mammalian hearts by activating a cardiac M3 receptor and a K+ current. Br J Pharmacol 126: 1725\u20131734.","DOI":"10.1038\/sj.bjp.0702486"},{"key":"10.1124\/jpet.107.133330_bib40","doi-asserted-by":"crossref","unstructured":"Xie W, Stribley JA, Chatonnet A, Wilder PJ, Rizzino A, McComb RD, Taylor P, Hinrichs SH, and Lockridge O (2000) Postnatal developmental delay and super-sensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 293: 896 \u2013902.","DOI":"10.1016\/S0022-3565(24)39312-7"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524343381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524343381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.133330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:33:53Z","timestamp":1740004433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524343381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0022356524343381"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.133330","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.133330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}